Gender |
|
|
Male |
50.0% |
8/16 |
Female |
50.0% |
8/16 |
Neurology |
|
|
Neurological abnormalities |
86.7% |
13/15 |
Tremor |
53.3% |
8/15 |
Muscular hypotonia |
46.7% |
7/15 |
Poor coordination |
13.3% |
2/15 |
Nystagmus |
6.7% |
1/15 |
Ataxia |
26.7% |
4/15 |
Spina bifida occulta |
6.7% |
1/15 |
Absence seizures |
20.0% |
3/15 |
Upper motor neuron dysfunction |
6.7% |
1/15 |
Oculomotor apraxia |
6.7% |
1/15 |
Generalized tonic-clonic seizures |
6.7% |
1/15 |
Developmental regression |
6.7% |
1/15 |
Focal seizures |
6.7% |
1/15 |
Generalized myoclonic seizures |
6.7% |
1/15 |
Toe walking |
6.7% |
1/15 |
Seizures |
26.7% |
4/15 |
Febrile seizures |
6.7% |
1/15 |
Myoclonus |
6.7% |
1/15 |
Behavioral problems |
50.0% |
8/16 |
Autism |
31.3% |
5/16 |
Behavioral abnormality |
6.3% |
1/16 |
Borderline personality disorder |
6.3% |
1/16 |
Hyperactivity |
6.3% |
1/16 |
Brain abnormality |
55.6% |
5/9 |
Cerebellar hypoplasia |
22.2% |
2/9 |
Cerebellar vermis hypoplasia |
11.1% |
1/9 |
Pontocerebellar atrophy |
11.1% |
1/9 |
Cerebellar vermis atrophy |
11.1% |
1/9 |
Hypoplasia of the corpus callosum |
11.1% |
1/9 |
Abnormality of the cerebral ventricles |
11.1% |
1/9 |
Facial abnormalities |
|
|
Abnormality of the eye |
50.0% |
7/14 |
Esotropia |
14.3% |
2/14 |
Strabismus |
35.7% |
5/14 |
Visual and hearing impairments |
|
|
Abnormal hearing |
6.3% |
1/16 |
Visual impairment |
6.3% |
1/16 |
Abnormal vision |
21.4% |
3/14 |
Amblyopia |
7.1% |
1/14 |
Hypermetropia |
14.3% |
2/14 |
Gastrointestinal |
|
|
Gastrointestinal abnormalities |
6.3% |
1/16 |
Episodic vomiting |
6.3% |
1/16 |
Constipation |
6.3% |
1/16 |
Urogenital |
|
|
Abnormality of the urogenital system |
12.5% |
2/16 |
Hydronephrosis |
6.3% |
1/16 |
Cryptorchidism |
6.3% |
1/16 |
Renal cyst |
6.3% |
1/16 |
Skeleton |
|
|
Skeletal abnormalities |
6.3% |
1/16 |
Knee flexion contracture |
6.3% |
1/16 |
Skin / Hair / Nails |
|
|
Abnormality of the skin/hair/nails |
6.3% |
1/16 |
Atopic dermatitis |
6.3% |
1/16 |
Endocrine / Immunological / Metabolic |
|
|
Abnormality of the endocrine system |
6.3% |
1/16 |
Hypoglycemia |
6.3% |
1/16 |
Abnormality of the metabolic system |
6.3% |
1/16 |
Hypercholesterolemia |
6.3% |
1/16 |